Fungal serotype-specific differences in bacterial-yeast interactions

References

• Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 2009; 23:525-30; PMID:19182676; http://dx.doi.org/10.1097/QAD.0b013e328322ffac
   PubMed Web of Science ®Google Scholar
• Littman ML, Schneierson SS. Cryptococcus neoformans in pigeon excreta in New York City. Am J Hyg 1959; 69:49-59; PMID:13626944
   PubMed Web of Science ®Google Scholar
• Neilson JB, Ivey MH, Bulmer GG. Cryptococcus neoformans: size range of infectious particles fro aerosolized soil. Infect Immun 1977; 17:634; PMID:332630
   PubMed Web of Science ®Google Scholar
• Levitz SM. The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis. Rev Infect Dis 1991; 13:1163; PMID:1775849; http://dx.doi.org/10.1093/clinids/13.6.1163
   PubMedGoogle Scholar
• Franzot SP, Salkin IF, Casadevall A. Cryptococcus neoformans var. grubii: separate varietal status for Cryptococcus neoformans serotype A isolates. J Clin Microbiol 1999; 37:838-40; PMID:9986871
   PubMed Web of Science ®Google Scholar
• Bennett JE, Kwon-Chung KJ, Theodore TS. Biochemical differences between serotypes of Cryptococcus neoformans. Sabouraudia 1978; 16:167-74; PMID:360440; http://dx.doi.org/10.1080/00362177885380231
   PubMedGoogle Scholar
• Kwon-Chung KJ. A new genus, filobasidiella, the perfect state of Cryptococcus neoformans. Mycologia 1975; 67:1197-200; PMID:765816; http://dx.doi.org/10.2307/3758842
   PubMed Web of Science ®Google Scholar
• Bhattacharjee AK, Bennett JE, Glaudemans CP. Capsular polysaccharides of Cryptococcus neoformans. Rev Infect Dis 1984; 6:619-24; PMID:6209768; http://dx.doi.org/10.1093/clinids/6.5.619
   PubMedGoogle Scholar
• Cherniak R, Sundstrom JB. Polysaccharide antigens of the capsule of Cryptococcus neoformans. Infect Immun 1994; 62:1507-12; PMID:8168912
   PubMed Web of Science ®Google Scholar
• Bennett JE, Kwon-Chung KJ, Howard DH. Epidemiologic differences among serotypes of Cryptococcus neoformans. Am J Epidemiol 1977; 105:582-6; PMID:326036
   PubMed Web of Science ®Google Scholar
• Kwon-Chung KJ, Bennett JE. Epidemiologic differences between the two varieties of Cryptococcus neoformans. Ame J Epidemiol 1984; 120:123-30; PMID:6377880
   PubMed Web of Science ®Google Scholar
• Steenbergen JN, Casadevall A. Prevalence of Cryptococcus neoformans var. neoformans (Serotype D) and Cryptococcus neoformans var. grubii (Serotype A) isolates in New York City. J Clin Microbiol 2000; 38:1974-6; PMID:10790132
   PubMed Web of Science ®Google Scholar
• Dromer F, Mathoulin S, Dupont B, Letenneur L, Ronin O. Individual and environmental factors associated with infection due to Cryptococcus neoformans serotype D. French Cryptococcosis Study Group. Clin Infect Dis 1996; 23:91-6; PMID:8816135; http://dx.doi.org/10.1093/clinids/23.1.91
   PubMed Web of Science ®Google Scholar
• Casadevall A, Perfect JR. Cryptococcus neoformans. ASM Press; 1998.
   Google Scholar
• Martinez LR, Garcia-Rivera J, Casadevall A. Cryptococcus neoformans var. neoformans (serotype D) strains are more susceptible to heat than C. neoformans var. grubii (serotype A) strains. J Clin Microbiol 2001; 39:3365-7; PMID:11526180; http://dx.doi.org/10.1128/JCM.39.9.3365-3367.2001
   PubMed Web of Science ®Google Scholar
• Desnos-Ollivier M, Patel S, Raoux-Barbot D, Heitman J, Dromer F, French Cryptococcosis Study G. Cryptococcosis Serotypes Impact Outcome and Provide Evidence of Cryptococcus neoformans Speciation. mBio 2015; 6; PMID:26060271; http://dx.doi.org/10.1128/mBio.00311-15
   PubMed Web of Science ®Google Scholar
• Steenbergen JN, Shuman HA, Casadevall A. Cryptococcus neoformans interactions with amoebae suggest an explanation for its virulence and intracellular pathogenic strategy in macrophages. Proc Natl Acad Sci U S A 2001; 98:15245-50; PMID:11742090; http://dx.doi.org/10.1073/pnas.261418798
   PubMed Web of Science ®Google Scholar
• Fournier PE, Richet H. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis 2006; 42:692-9; PMID:16447117; http://dx.doi.org/10.1086/500202
   PubMed Web of Science ®Google Scholar
• Mihu MR, Martinez LR. Novel therapies for treatment of multi-drug resistant Acinetobacter baumannii skin infections. Virulence 2011; 2:97-102; PMID:21321482; http://dx.doi.org/10.4161/viru.2.2.15061
   PubMed Web of Science ®Google Scholar
• Wargo MJ, Hogan DA. Fungal–bacterial interactions: a mixed bag of mingling microbes. Curr Opin Microbiol 2006; 9:359-64; PMID:16777473; http://dx.doi.org/10.1016/j.mib.2006.06.001
   PubMed Web of Science ®Google Scholar
• Hall-Stoodley L, Costerton JW, Stoodley P. Bacterial biofilms: from the natural environment to infectious diseases. Nat Rev Microbiol 2004; 2:95-108; PMID:15040259; http://dx.doi.org/10.1038/nrmicro821
   PubMed Web of Science ®Google Scholar
• Goldman DL, Lee SC, Casadevall A. Tissue localization of Cryptococcus neoformans glucuronoxylomannan in the presence and absence of specific antibody. Infect Immun 1995; 63:3448-53; PMID:7642276
   PubMed Web of Science ®Google Scholar
• Derengowski Lda S, Paes HC, Albuquerque P, Tavares AH, Fernandes L, Silva-Pereira I, Casadevall A. The transcriptional response of Cryptococcus neoformans to ingestion by Acanthamoeba castellanii and macrophages provides insights into the evolutionary adaptation to the mammalian host. Eukaryot Cell 2013; 12:761-74; PMID:23524994; http://dx.doi.org/10.1128/EC.00073-13
   PubMed Web of Science ®Google Scholar
• Murga R, Forster TS, Brown E, Pruckler JM, Fields BS, Donlan RM. Role of biofilms in the survival of Legionella pneumophila in a model potable-water system. Microbiology 2001; 147:3121-6; PMID:11700362
   PubMed Web of Science ®Google Scholar
• Jesaitis AJ, Franklin MJ, Berglund D, Sasaki M, Lord CI, Bleazard JB, Duffy JE, Beyenal H, Lewandowski Z. Compromised host defense on Pseudomonas aeruginosa biofilms: characterization of neutrophil and biofilm interactions. J Immunol 2003; 171:4329-39; PMID:NOT_FOUND; http://dx.doi.org/10.4049/jimmunol.171.8.4329
   PubMed Web of Science ®Google Scholar
• Rijnaarts HH, Norde W, Bouwer EJ, Lyklema J, Zehnder AJ. Bacterial adhesion under static and dynamic conditions. Appl Environ Microbiol 1993; 59:3255-65; PMID:16349063
   PubMed Web of Science ®Google Scholar
• Uppuluri P, Chaturvedi AK, Srinivasan A, Banerjee M, Ramasubramaniam AK, Kohler JR, Kadosh D, Lopez-Ribot JL. Dispersion as an important step in the Candida albicans biofilm developmental cycle. PLoS Pathog 2010; 6:e1000828.
   PubMed Web of Science ®Google Scholar
• Stoodley P, Hall-Stoodley L, Lappin-Scott HM. Detachment, surface migration, and other dynamic behavior in bacterial biofilms revealed by digital time-lapse imaging. Methods Enzymol 2001; 337:306-19; PMID:11398439; http://dx.doi.org/10.1016/S0076-6879(01)37023-4
   PubMed Web of Science ®Google Scholar
• Robbins N, Uppuluri P, Nett J, Rajendran R, Ramage G, Lopez-Ribot JL, Andes D, Cowen LE. Hsp90 governs dispersion and drug resistance of fungal biofilms. PLoS Pathog 2011; 7:e1002257; PMID:21931556; http://dx.doi.org/10.1371/journal.ppat.1002257
   PubMed Web of Science ®Google Scholar
• Rice SA, Koh KS, Queck SY, Labbate M, Lam KW, Kjelleberg S. Biofilm formation and sloughing in Serratia marcescens are controlled by quorum sensing and nutrient cues. J Bacteriol 2005; 187:3477-85; PMID:15866935; http://dx.doi.org/10.1128/JB.187.10.3477-3485.2005
   PubMed Web of Science ®Google Scholar
• Rivera J, Feldmesser M, Cammer M, Casadevall A. Organ-dependent variation of capsule thickness in Cryptococcus neoformans during experimental murine infection. Infect Immun 1998; 66:5027-30; PMID:9746613
   PubMed Web of Science ®Google Scholar
• Tucker SC, Casadevall A. Replication of Cryptococcus neoformans in macrophages is accompanied by phagosomal permeabilization and accumulation of vesicles containing polysaccharide in the cytoplasm. Proc Natl Acad Sci U S A 2002; 99:3165-70; PMID:11880650; http://dx.doi.org/10.1073/pnas.052702799
   PubMed Web of Science ®Google Scholar
• Martinez LR, Casadevall A. Specific antibody can prevent fungal biofilm formation and this effect correlates with protective efficacy. Infect Immun 2005; 73:6350-62; PMID:16177306; http://dx.doi.org/10.1128/IAI.73.10.6350-6362.2005
   PubMed Web of Science ®Google Scholar
• Alvarez M, Saylor C, Casadevall A. Antibody action after phagocytosis promotes Cryptococcus neoformans and Cryptococcus gattii macrophage exocytosis with biofilm-like microcolony formation. Cell Microbiol 2008; 10:1622-33; PMID:18384661; http://dx.doi.org/10.1111/j.1462-5822.2008.01152.x
   PubMed Web of Science ®Google Scholar
• Vecchiarelli A. Immunoregulation by capsular components of Cryptococcus neoformans. Med Mycol 2000; 38:407-17; PMID:11204878; http://dx.doi.org/10.1080/mmy.38.6.407.417
   PubMed Web of Science ®Google Scholar
• Granger DL, Perfect JR, Durack DT. Virulence of Cryptococcus neoformans. Regulation of capsule synthesis by carbon dioxide. J Clin Invest 1985; 76:508-16; PMID:3928681; http://dx.doi.org/10.1172/JCI112000
   PubMed Web of Science ®Google Scholar
• Vartivarian SE, Anaissie EJ, Cowart RE, Sprigg HA, Tingler MJ, Jacobson ES. Regulation of cryptococcal capsular polysaccharide by iron. J Infect Dis 1993; 167:186-90; PMID:8418165; http://dx.doi.org/10.1093/infdis/167.1.186
   PubMed Web of Science ®Google Scholar
• Bahn YS, Kojima K, Cox GM, Heitman J. Specialization of the HOG pathway and its impact on differentiation and virulence of Cryptococcus neoformans. Mol Biol Cell 2005; 16:2285-300; PMID:15728721; http://dx.doi.org/10.1091/mbc.E04-11-0987
   PubMed Web of Science ®Google Scholar
• Cramer KL, Gerrald QD, Nichols CB, Price MS, Alspaugh JA. Transcription factor Nrg1 mediates capsule formation, stress response, and pathogenesis in Cryptococcus neoformans. Eukaryot Cell 2006; 5:1147-56; PMID:16835458; http://dx.doi.org/10.1128/EC.00145-06
   PubMed Web of Science ®Google Scholar
• Hu G, Steen BR, Lian T, Sham AP, Tam N, Tangen KL, Kronstad JW. Transcriptional regulation by protein kinase A in Cryptococcus neoformans. PLoS Pathog 2007; 3:e42; PMID:17367210; http://dx.doi.org/10.1371/journal.ppat.0030042
   PubMed Web of Science ®Google Scholar
• Xue C, Bahn YS, Cox GM, Heitman J. G protein-coupled receptor Gpr4 senses amino acids and activates the cAMP-PKA pathway in Cryptococcus neoformans. Mol Biol Cell 2006; 17:667-79; PMID:16291861; http://dx.doi.org/10.1091/mbc.E05-07-0699
   PubMed Web of Science ®Google Scholar
• Cordero RJ, Frases S, Guimaraes AJ, Rivera J, Casadevall A. Evidence for branching in cryptococcal capsular polysaccharides and consequences on its biological activity. Mol Microbiol 2011; 79:1101-17; PMID:21208301; http://dx.doi.org/10.1111/j.1365-2958.2010.07511.x
   PubMed Web of Science ®Google Scholar
• Rodrigues ML, Nimrichter L, Oliveira DL, Frases S, Miranda K, Zaragoza O, Alvarez M, Nakouzi A, Feldmesser M, Casadevall A. Vesicular polysaccharide export in Cryptococcus neoformans is a eukaryotic solution to the problem of fungal trans-cell wall transport. Eukaryot Cell 2007; 6:48-59; PMID:17114598; http://dx.doi.org/10.1128/EC.00318-06
   PubMed Web of Science ®Google Scholar
• Eveillard M, Kempf M, Belmonte O, Pailhories H, Joly-Guillou ML. Reservoirs of Acinetobacter baumannii outside the hospital and potential involvement in emerging human community-acquired infections. Int J Infect Dis 2013; 17:e802-5; PMID:23672981; http://dx.doi.org/10.1016/j.ijid.2013.03.021
   PubMed Web of Science ®Google Scholar
• Orsinger-Jacobsen SJ, Patel SS, Vellozzi EM, Gialanella P, Nimrichter L, Miranda K, Martinez LR. Use of a stainless steel washer platform to study Acinetobacter baumannii adhesion and biofilm formation on abiotic surfaces. Microbiology 2013; 159:2594-604; PMID:24025603; http://dx.doi.org/10.1099/mic.0.068825-0
   PubMed Web of Science ®Google Scholar
• Patel D, Desai GM, Frases S, Cordero RJ, DeLeon-Rodriguez CM, Eugenin EA, Nosanchuk JD, Martinez LR. Methamphetamine enhances Cryptococcus neoformans pulmonary infection and dissemination to the brain. mBio 2013; 4; PMID:AMBIGUOUS; http://dx.doi.org/10.1128/mBio.00400-13
   PubMedGoogle Scholar
• Martinez LR, Moussai D, Casadevall A. Antibody to Cryptococcus neoformans glucuronoxylomannan inhibits the release of capsular antigen. Infect Immun 2004; 72:3674-9; PMID:15155683; http://dx.doi.org/10.1128/IAI.72.6.3674-3679.2004
   PubMed Web of Science ®Google Scholar